Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480746/
https://www.ncbi.nlm.nih.gov/pubmed/32943875
http://dx.doi.org/10.2147/OTT.S278185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480746/
https://www.ncbi.nlm.nih.gov/pubmed/32943875
http://dx.doi.org/10.2147/OTT.S278185

Ejemplares similares